Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs GSK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CIPLA GSK PHARMA CIPLA/
GSK PHARMA
 
P/E (TTM) x 32.2 62.2 51.8% View Chart
P/BV x 5.2 18.9 27.4% View Chart
Dividend Yield % 0.6 1.6 34.5%  

Financials

 CIPLA   GSK PHARMA
EQUITY SHARE DATA
    CIPLA
Mar-23
GSK PHARMA
Mar-23
CIPLA/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs1,1851,684 70.4%   
Low Rs8521,231 69.2%   
Sales per share (Unadj.) Rs281.9191.9 146.9%  
Earnings per share (Unadj.) Rs35.135.9 97.9%  
Cash flow per share (Unadj.) Rs49.739.8 124.9%  
Dividends per share (Unadj.) Rs8.5032.00 26.6%  
Avg Dividend yield %0.82.2 38.0%  
Book value per share (Unadj.) Rs289.2102.9 281.1%  
Shares outstanding (eoy) m807.15169.41 476.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.67.6 47.6%   
Avg P/E ratio x29.040.6 71.4%  
P/CF ratio (eoy) x20.536.7 56.0%  
Price / Book Value ratio x3.514.2 24.9%  
Dividend payout %24.289.2 27.1%   
Avg Mkt Cap Rs m822,164246,858 333.1%   
No. of employees `000NANA-   
Total wages/salary Rs m38,3015,950 643.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m227,53132,517 699.7%  
Other income Rs m5,1211,007 508.8%   
Total revenues Rs m232,65333,524 694.0%   
Gross profit Rs m48,0798,033 598.5%  
Depreciation Rs m11,721658 1,782.2%   
Interest Rs m1,09518 6,045.3%   
Profit before tax Rs m40,3848,364 482.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m12,0292,288 525.8%   
Profit after tax Rs m28,3556,076 466.6%  
Gross profit margin %21.124.7 85.5%  
Effective tax rate %29.827.4 108.9%   
Net profit margin %12.518.7 66.7%  
BALANCE SHEET DATA
Current assets Rs m168,05124,943 673.7%   
Current liabilities Rs m50,33313,264 379.5%   
Net working cap to sales %51.735.9 144.0%  
Current ratio x3.31.9 177.5%  
Inventory Days Days7397 75.3%  
Debtors Days Days7216 3.0%  
Net fixed assets Rs m117,3186,988 1,678.9%   
Share capital Rs m1,6141,694 95.3%   
"Free" reserves Rs m231,84515,735 1,473.4%   
Net worth Rs m233,46017,430 1,339.5%   
Long term debt Rs m00-   
Total assets Rs m290,06731,930 908.4%  
Interest coverage x37.9462.6 8.2%   
Debt to equity ratio x00-  
Sales to assets ratio x0.81.0 77.0%   
Return on assets %10.219.1 53.2%  
Return on equity %12.134.9 34.8%  
Return on capital %17.848.1 36.9%  
Exports to sales %22.60-   
Imports to sales %8.948.1 18.5%   
Exports (fob) Rs m51,516NA-   
Imports (cif) Rs m20,20215,630 129.3%   
Fx inflow Rs m64,2821,622 3,963.9%   
Fx outflow Rs m20,20215,630 129.3%   
Net fx Rs m44,080-14,008 -314.7%   
CASH FLOW
From Operations Rs m32,3774,842 668.6%  
From Investments Rs m-23,8858,079 -295.7%  
From Financial Activity Rs m-9,583-15,433 62.1%  
Net Cashflow Rs m-968-2,512 38.5%  

Share Holding

Indian Promoters % 13.4 0.0 -  
Foreign collaborators % 20.0 75.0 26.7%  
Indian inst/Mut Fund % 50.0 11.6 431.7%  
FIIs % 25.7 2.9 878.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 66.5 25.0 266.1%  
Shareholders   425,731 114,663 371.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CIPLA With:   DIVIS LABORATORIES    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Cipla vs GSK Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cipla vs GSK Pharma Share Price Performance

Period Cipla GSK Pharma S&P BSE HEALTHCARE
1-Day 1.94% 3.26% 1.18%
1-Month 1.25% -9.77% -0.75%
1-Year 68.02% 52.63% 61.82%
3-Year CAGR 22.53% 10.89% 18.16%
5-Year CAGR 23.24% 8.44% 19.79%

* Compound Annual Growth Rate

Here are more details on the Cipla share price and the GSK Pharma share price.

Moving on to shareholding structures...

The promoters of Cipla hold a 33.5% stake in the company. In case of GSK Pharma the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cipla and the shareholding pattern of GSK Pharma.

Finally, a word on dividends...

In the most recent financial year, Cipla paid a dividend of Rs 8.5 per share. This amounted to a Dividend Payout ratio of 24.2%.

GSK Pharma paid Rs 32.0, and its dividend payout ratio stood at 89.2%.

You may visit here to review the dividend history of Cipla, and the dividend history of GSK Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.